Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of ketamine and risperidone on eye movement control in healthy volunteers.
Schmechtig A, Lees J, Perkins A, Altavilla A, Craig KJ, Dawson GR, William Deakin JF, Dourish CT, Evans LH, Koychev I, Weaver K, Smallman R, Walters J, Wilkinson LS, Morris R, Williams SC, Ettinger U. Schmechtig A, et al. Transl Psychiatry. 2013 Dec 10;3(12):e334. doi: 10.1038/tp.2013.109. Transl Psychiatry. 2013. PMID: 24326395 Free PMC article. Clinical Trial.
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Koychev I, McMullen K, Lees J, Dadhiwala R, Grayson L, Perry C, Schmechtig A, Walters J, Craig KJ, Dawson GR, Dourish CT, Ettinger U, Wilkinson L, Williams S, Deakin JF, Barkus E. Koychev I, et al. Among authors: schmechtig a. Eur Neuropsychopharmacol. 2012 Jul;22(7):469-81. doi: 10.1016/j.euroneuro.2011.10.005. Epub 2011 Dec 3. Eur Neuropsychopharmacol. 2012. PMID: 22137565 Clinical Trial.
Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.
Schmechtig A, Lees J, Grayson L, Craig KJ, Dadhiwala R, Dawson GR, Deakin JF, Dourish CT, Koychev I, McMullen K, Migo EM, Perry C, Wilkinson L, Morris R, Williams SC, Ettinger U. Schmechtig A, et al. Psychopharmacology (Berl). 2013 May;227(2):331-45. doi: 10.1007/s00213-013-2973-4. Epub 2013 Feb 22. Psychopharmacology (Berl). 2013. PMID: 23430159 Clinical Trial.
Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study.
Kumari V, Ettinger U, Lee SE, Deuschl C, Anilkumar AP, Schmechtig A, Corr PJ, Ffytche DH, Williams SC. Kumari V, et al. Among authors: schmechtig a. Psychopharmacology (Berl). 2015 Sep;232(17):3135-47. doi: 10.1007/s00213-015-3959-1. Epub 2015 May 19. Psychopharmacology (Berl). 2015. PMID: 25980483 Free PMC article. Clinical Trial.
Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study.
Quednow BB, Schmechtig A, Ettinger U, Petrovsky N, Collier DA, Vollenweider FX, Wagner M, Kumari V. Quednow BB, et al. Among authors: schmechtig a. Biol Psychiatry. 2009 Sep 15;66(6):614-20. doi: 10.1016/j.biopsych.2009.05.007. Epub 2009 Jun 28. Biol Psychiatry. 2009. PMID: 19545856 Free PMC article.
19 results